Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
ShareProperty is a property crowdfunding platform that allows you, the investor to select your investment according to your own risk profile and required rate of return. ShareProperty allows you to build and manage your own property portfolio, hold your investment to term or resell on the ShareProperty trading exchange.
days to go:
Expired
investment:
£149,002
PRESS is a health food and nutrition business specialising in Cold-Pressed juices, snacks, smoothies, soups and supplements.Our products bring healthy, delicious recipes to the hands of those customers looking to make positive decisions when it comes to what, when and how they eat and drink
days to go:
Expired
investment:
£1,114,540
Launched in 2017, Algarve Rock is on a mission to put Portuguese craft beer on the map with flavoursome beers that embody local ingredients. The global craft beer market is expected to reach nearly $187 billion by 2025. It has carved a niche for itself in only 18 months of its inception. The 3,000 litre Brew House associated fermentation vessels and auto bottling line allow them to produce 36,000 litres per month, readily expandable to 80,000 litres to meet growing demand. Algarve Rock was the winner of the Best Stout - Trujillo Festival 2018, Spain and is the house brewer for prestigious institutions like Quinta do Lago group and Casa do Frango restaurants in London. With the investment, the company will use 40% to open Algarve Rock-themed Brewbars and Brew kiosks, 10% in increasing exports especially to the UK and USA, 10% in strengthening brand identity, 15% in recruitment procedures, and 25% in increasing brewing capacity to cater to new markets.
days to go:
Expired
investment:
£281,607
A brewery, gin distillery, bar and kitchen business. Love Lane Brewery is based in Liverpool and produces around 18,000 hectolitres of beer per year. In 2017, the company generated revenues of £300k; in 2018, they achieved £1m in revenue and have 60 clients that sell their Love Lane Pale Ale. The company also offers an event space and tours of their sites.
Love Lane Brewery will invest in their brand by increasing their sale and distribution channels, with the intent of marketing their products directly to consumers. Funds will also be allocated towards their infrastructure, primarily in their warehouse and brewery to purchase equipment such as hop cannons, cold stores, racking, augers, etc.
days to go:
Expired
investment:
£1,051,680
SEVEN BRO7HERS Brewery was established to produce exceptional beer for both Manchester and further regions, boasting revenue exceeding £5 million in 2022. Actually owned by seven brothers, they're expanding in the UK retail market to capitalize on the thriving craft beer industry, utilizing opportunities such as enhanced supermarket presence, increased footfall at Manchester Airport, and establishing a permanent Manchester hub for artisan product enthusiasts and investment will be pivotal in bringing this vision to life.
days to go:
Expired
investment:
£504,242
